Literature DB >> 2987359

A whole-blood lymphoproliferation assay for measuring cellular immunity against herpes viruses.

M Leroux, L Schindler, R Braun, H W Doerr, H P Geisen, H Kirchner.   

Abstract

A whole blood test system was established to study cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) in a large number of healthy blood donors. Cellular immunity was measured by the in vitro proliferative response (LP) of peripheral lymphocytes. These responded vigorously to several mitogens. Lymphocytes of most individuals responded to HSV, but only a limited number were reactive towards CMV. In parallel, antibodies against CMV and HSV were measured by an ELISA technique. For HSV, good correlation was observed between serological and lymphocyte proliferation results. For CMV, no clear correlation was obtained, only 21 of 40 donors positive in the antibody test being positive in the LP test. The majority of seronegatives were negative in the LP test. Use of virions purified by sucrose gradient centrifugation, or an additional strain of CMV (strain Davis) did not increase the number of donors positive in the LP test. One explanation might be that individuals possessing antibodies against CMV as measured by ELISA but no capacity to react in the LP test had suffered from a CMV infection a long time before, and now showed waning cellular immunity, but antibody still detectable. Use of the whole blood technique on 108 individuals showed that this very simple test works well with various mitogens and at least some antigens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2987359     DOI: 10.1016/0022-1759(85)90105-x

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

1.  CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.

Authors:  Elizabeth Sinclair; Douglas Black; C Lorrie Epling; Alexander Carvidi; Steven Z Josefowicz; Barry M Bredt; Mark A Jacobson
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

2.  Correlation between interferon production and clinical disease activity in patients with multiple sclerosis.

Authors:  M Dettke; P Scheidt; H Prange; H Kirchner
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma.

Authors:  H P Eck; P Drings; W Dröge
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

4.  Reversal of defective lymphoproliferation in postoperative patients with colon cancer.

Authors:  L Schindler; M Leroux; G F Zimmermann; M Betzler; H Kirchner
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Production of interferon and lymphoproliferative response in whole blood cultures derived from patients with atopic dermatitis.

Authors:  A Kapp; R Gillitzer; H Kirchner; E Schöpf
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

6.  Human cytomegalovirus infection: recent developments in diagnosis and epidemiology.

Authors:  H W Doerr; R Braun; K Munk
Journal:  Klin Wochenschr       Date:  1985-03-15

7.  T-cell proliferative response to human papillomavirus type 16 peptides: relationship to cervical intraepithelial neoplasia.

Authors:  M Nakagawa; D P Stites; S Farhat; A Judd; A B Moscicki; A J Canchola; J F Hilton; J M Palefsky
Journal:  Clin Diagn Lab Immunol       Date:  1996-03

8.  Micronutrient deficiencies are associated with impaired immune response and higher burden of respiratory infections in elderly Ecuadorians.

Authors:  Davidson H Hamer; Fernando Sempértegui; Bertha Estrella; Katherine L Tucker; Alicia Rodríguez; Josefina Egas; Gerard E Dallal; Jacob Selhub; Jeffrey K Griffiths; Simin Nikbin Meydani
Journal:  J Nutr       Date:  2008-12-03       Impact factor: 4.798

Review 9.  Whole blood assay and visceral leishmaniasis: Challenges and promises.

Authors:  Om Prakash Singh; Shyam Sundar
Journal:  Immunobiology       Date:  2014-01-31       Impact factor: 3.144

10.  Plasma glutamate concentration and lymphocyte activity.

Authors:  W Dröge; H P Eck; M Betzler; P Schlag; P Drings; W Ebert
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.